At present, more than 60 million people in the EU live with cardiovascular diseases (CVD), which remain the main cause of death and disability in Europe, accounting for over €282 billion in healthcare expenditure in the EU every year. The upcoming Council Conclusions on cardiovascular health (CVH) that the Hungarian Presidency is working on, along with the inclusion of CVD in both the European Commission President’s political guidelines and the Mission Letter to the Commissioner-Designate for Health signal a much welcome political commitment towards improving cardiovascular health (CVH) in Europe.

Building on this momentum, this event aims to provide a platform for discussion between EU and national-level stakeholders to explore ways to address CVH in Europe, reduce mortality and morbidity, and improve the quality of life of people living with or at risk of CVD.

This event will explore how to best focus EU-level action towards the unmet needs of the cardiovascular community and ensure that the new EU mandate puts forward the right tools to support the communities and the Member States in promoting CVH. The event will also see the participation of representatives of the national Health Ministries, to draw on national best practices and on the learnings of countries that have recently developed national cardiovascular health plans or other strategies to tackle CVD.

The event will be moderated by Prof. Michal Vrablik, Professor of Internal Medicine at Charles University in Prague, the Czech Republic. Speakers will include Members of the European Parliament, representatives from the European Commission, representatives of the Hungarian Presidency of the Council of the EU and patient representatives.

We will welcome guests from 15:30 for a coffee. The event will be followed by a networking reception.

Please join us and stay tuned for more details!

Date: 18 November 2024

Location: The Hotel Brussels – 38 Boulevard de Waterloo 1000 Bruxelles